Vaxcyte
PCVX
#2383
Rank
A$11.30 B
Marketcap
A$78.27
Share price
-1.76%
Change (1 day)
40.36%
Change (1 year)

Earnings for Vaxcyte (PCVX)

Earnings in 2026 (TTM): -A$1.41 Billion

According to Vaxcyte 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$1.1 Billion a decrease over its 2024 earnings that were of -A$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vaxcyte from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.41 Billion28.12%
2025 -A$1.1 Billion65.25%
2024 -A$0.67 Billion15.33%
2023 -A$0.58 Billion80%
2022 -A$0.33 Billion123.31%
2021 -A$0.15 Billion12.17%
2020 -A$0.13 Billion77.46%
2019 -A$72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.22 Billion-84.16%๐Ÿ‡บ๐Ÿ‡ธ USA